Dear K.T.: Dexfenfluramine, aka Redux (also called "fen-phen" in combination with phentermine), was sold in the 1990s until ...
MedPage Today on MSN2d
Sotatercept Helps the Sickest Patients With Pulmonary Arterial HypertensionAdding sotatercept (Winrevair) to the treatment regimen for pulmonary arterial hypertension (PAH) in high-risk patients ...
Main pulmonary artery diameter is a prognostic indicator in patients with pulmonary arterial hypertension without congenital heart disease.
Marc Humbert, M.D., Ph.D., professor of respiratory medicine at Université Paris-Saclay and Inserm, believes that recent ...
Sotatercept, an activin signaling inhibitor, was associated with improved outcomes in patients with advanced pulmonary ...
The primary end point was a composite of death from any cause, lung transplantation, or hospitalization (≥24 hours) for worsening pulmonary arterial hypertension, assessed in a time-to-first ...
Patients taking sotatercept had a 76% relative risk reduction in morbidity and mortality events compared with patients taking ...
Another study testing sotatercept as an early intervention for pulmonary arterial hypertension (PAH) is anticipated to ...
The seventh edition of the International Meeting on Pulmonary Hypertension Clinical Treatment (IMPAHCT), organized by ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback